Summit Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.6M | 270k | 20.66 |
| 2025-06-30 | $5.7M | 268k | 21.28 |
| 2025-03-31 | $8.2M | 428k | 19.29 |
| 2024-12-31 | $8.5M | 479k | 17.85 |
| 2024-09-30 | $8.7M | 398k | 21.90 |
| 2024-06-30 | $372k | 48k | 7.80 |
| 2024-03-31 | $296k | 72k | 4.14 |
| 2023-12-31 | $191k | 73k | 2.61 |
| 2023-09-30 | $122k | 65k | 1.87 |
| 2023-06-30 | $135k | 54k | 2.51 |
| 2022-03-31 | $35k | 14k | 2.45 |
| 2021-12-31 | $43k | 16k | 2.69 |
| 2021-09-30 | $76k | 15k | 5.01 |
| 2021-06-30 | $100k | 13k | 7.49 |
| 2021-03-31 | $0 | 9 | 0.00 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft